Chargement en cours...
Peroxiredoxin 2 is associated with colorectal cancer progression and poor survival of patients
The present study was to investigate the clinical significance of peroxiredoxin 2 (PRDX2), an oncoenzyme, in the development and progression of colorectal cancer(CRC).We found levels of PRDX2 mRNA and protein were higher in CRC cell lines than in normal human colonic epithelial cells. PRDX2 expressi...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5362467/ https://ncbi.nlm.nih.gov/pubmed/28125800 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14801 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|